The 9th World Cancer Congress – 2026 was successfully organized on 20th – 21st March 2026 at the prestigious JNU Convention Centre, New Delhi, India. The congress served as a premier global platform bringing together oncologists, clinicians, scientists, academicians, healthcare professionals, and industry experts.
The congress aimed to bridge the gap between basic science and clinical research, focusing on cancer genesis, progression, prevention, diagnosis, and treatment. It emphasized translational research and integrative medicine approaches to improve patient outcomes and global cancer care.
The 9th World Cancer Congress – 2026 featured a meticulously curated scientific agenda covering multidisciplinary aspects of oncology, including cancer prevention, early diagnosis, clinical treatment, translational research, immunotherapy, molecular oncology, precision medicine, and integrative oncology approaches.
The 9th WCC witnessed outstanding scientific participation, receiving a large number of research contributions, and successfully hosted 10+ Keynote Talks, 100+ Oral Presentations, and 150+ Poster Presentations over the two-day congress.
The congress hosted multiple high-impact sessions across both days, covering all major domains of cancer research and clinical practice such as tumor microenvironment, cancer immunotherapy, molecular oncology, radiation biology, clinical oncology, cancer epidemiology, AI in cancer diagnosis, precision oncology, survivorship care, and integrative medicine.
The congress also featured thematic tracks addressing global challenges in cancer control at international, national, and regional levels. Participants engaged in insightful keynote lectures by global experts, invited talks from leading researchers, panel discussions on emerging trends like AI in oncology, and interactive scientific presentations, fostering knowledge exchange and collaboration.
The event further provided a platform for young researchers and early-career scientists through oral and poster presentations, encouraging innovation and future advancements in cancer research.
Prof. Parameswaran Ramakrishnan, Case Western Reserve University and Louis Stokes Cleveland Veterans, Affairs Medical Center, Cleveland, Ohio, USA
Dr. Abhishek Mohanty, Centre for Biorepository and Biobanking, Health Care Global Cancer Centre Bangalore, India
Dr. Gauri Mishra, National Institute of Biologics, Noida, India
Dr. Deovrat Begde, Curo Biosciences Pvt. Ltd. Nagpur, India
Shalini, Dept. of Zoology, B R Ambedkar University, Muzaffarpur, India
Dr. Saarthak Miglani, Dept. of Radiation Oncology, Maulana Azad Medical College, Delhi
Priyadarshini Singh, CSIR-Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad, Telangana, India
Prateekshya Das, CSIR-Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad, Telangana, India
We extend our sincere gratitude to Jawaharlal Nehru University (JNU) for hosting the conference at its prestigious convention centre.
We express our heartfelt thanks to our Chair, Prof. Ajit K. Saxena, for his visionary leadership and guidance throughout the congress.
We also thank all sponsors, collaborators, and supporting partners for their invaluable contributions. Their continuous support played a crucial role in the success of the conference.
Finally, we appreciate all speakers, delegates, and participants whose active involvement made this event highly successful and impactful.